Ann: Outstanding SubB2M Ovarian Cancer Test Data, page-377

Yes to the doubters I am a Doctor. Yes I went through issues - well picked up by one punter. Its called Bipolar Type 2.
I have managed it with professional help, hence I trade a little these days. I used to fall in love with stocks as I
did many things .Enough said

The key for me is the Specificity and Sensitivity.

In other words Specificity means that people who are without the disease of Ovarian cancer- have a negative test.

Important- as you don't have to go down the loop of pelvic u/s, Ct and laparoscopy. You can reassure.

Sensitivity means you pick up all those who do have early ovarian cancer regardless of what the other tests say- so you pursue it to
the 'Nth' degree, as the care provider.

CEA (the current test) is useless as a screening Tool. U/S a little better. Only 1 in 40 positive tests have ovarian cancer. That's a lot of stupid anxiety for the woman.

As I said early days, small sample.

But this would be a game changer and for big Pharma it's a easy pick up - If the believe the veracity of the science and the management team.

Are they circling?

Trading suggests more then Hot Copper punters been the main source of the upswing, bots buying @ 1.83-1.84

I look forward to Monday.

MC @ 130 million.

+21 million bought on Friday.

Bring it on.

These are silly times in the Market-where to put %, Bitcoin, Li, Tin, Cu, E. Musk twitters something etc. etc.

But with nothing else to invest in- we invest it potential and dreams, no different then tulip bulbs (16th c something Modern day Holland) - but they
did not have a potential simple diagnostic test game changer


Finch

Perth